Mosqueda, Salmah T.
HRN: 22-60-15 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/11/2023
CEFUROXIME 500MG (TAB)
02/11/2023
02/18/2023
PO
500 Mg
BID
Thinly Meconium-Stained Amniotic Fluid
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive TractProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes